2012 Parties Already Being Booked for Ibiza, Spain

Ibiza, the Spanish idyll roughly 80 km off the coast of Valencia has already got the wheels in motion for its world-famous party season.

2011-12-29

LONDON, ENGLAND, December 29, 2011 (Press-News.org) Ibiza remains known as one of Europe's most popular best party destinations - the Balearic islands were one of the top 50 destinations in 2011 for UK travellers and there was more bookings for Ibiza that year than in any other. And for the 2012 season parties are already been booked. Ibiza's official opening weekend for 2012 will be Friday, 27 May, through Saturday, 28 May.

The first party that's been confirmed for the 2012 season happens on Wednesday, 6 June 2012, at Ibiza Rocks Hotel. Ibiza Rocks is a music festival that's been happening each year in Ibiza since 2005 and attracts a fresh, new audience to the town of San Antonio. The line-up for Ibiza Rocks' upcoming summer has yet to be announced, but fans anticipate another year of extraordinary bands and DJs. The 2011 line-up included artists such as Fatboy Slim, Zane Lowe, The Wombats, Johnny Borrell, and many others. As for the location, the Ibiza Rocks Hotel features daily pool parties, two bars, a restaurant, a video game room, and several other amenities which make it one of the top destination hotels in Europe.

The other big-name clubs in Ibiza will be announcing their own opening weekend parties soon. Some of the clubs to watch out for include:

Privilege: A club that's hosted some of Ibiza's most famous parties, Privilege is literally the largest nightclub in the world. With ceilings 25-metres high, Privilege has a huge pool inside and gets redesigned for new parties nearly every night of the season.
Pacha: Pacha is much smaller than Privilege, with a capacity of about 300 people. Unlike some of the island's other clubs, Pacha has a high-class vibe that attracts trendy Spaniards as well as holidaymakers.

Amnesia: For holidaymakers searching for the best techno and trance music on the island, Amnesia is the place to be. Attracting DJs like Paul Van Dyke, Tiesto, and Carl Cox, Amnesia prides itself on sound quality and dance parties.

About Expedia
Expedia, Inc. is the world's leading online travel company, empowering business and leisure travellers with the tools and information they need to easily research, plan, book and experience travel. Expedia, Inc. also provides in-destination concierge service and activity desks for travellers. The Expedia, Inc. portfolio of brands includes: Expedia.com, hotels.com, Hotwire, Egencia (formerly Expedia Corporate Travel), TripAdvisor, Expedia Local Expert, Classic Vacations and eLong. Expedia, Inc.'s companies operate more than 70 global points of sale in more than 40 countries, with sites in North America, South America, Latin America, Europe, Middle East, Africa and Asia Pacific. Expedia, Inc. is a component of the S&P 500 index. For more information, visit http://www.expediainc.com/ (NASDAQ: EXPE).

With access to 140,000 hotels around the world (including boutique hotels as well as major hotel brand names),over 300 airlines along with specialist tools to help refine these choices, Expedia UK helps travellers to find and create the trip that best matches their individual requirements. Expedia is a registered trademark of Expedia, Inc. in the European Union and certain other jurisdictions. All other trademarks are property of their respective owners. 2011 Expedia, Inc.

Contact details:
Jill Lloyd - Expedia UK
+44 2070192763
jlloyd@expedia.com

ELSE PRESS RELEASES FROM THIS DATE:

Association of cognitive function in adolescence and subsequent risk of subdural hematoma

2011-12-29

Anna Nordström and Peter Nordström of Umeå University, Sweden report their analysis of a prospective nationwide cohort of 440,742 Swedish men in this week's PLoS Medicine, finding that reduced cognitive function in young adulthood was associated with increased risk of subdural hematoma later in life, whereas a higher level of education and physical fitness were associated with a decreased risk. These results need to be confirmed in other large studies. The authors say: "An exploration of the mechanistic basis for these associations might allow the construction of public ...

More information on trial site investigators needed

2011-12-29

Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance. In this week's PLoS Medicine, Rafael Dal-Ré and colleagues argue that that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts, as well as their final recruitment. Information on issues that could have affected recruitment should also be provided. This information will be of interest to different stakeholders such as patient organizations, ...

Another potential obstacle to developing an HIV vaccine

2011-12-29

A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]). A team of researchers led by Juliana McElrath, at the Fred Hutchinson Cancer Research Center, Seattle, has now determined that individuals from the STEP study ...

Does LASIK Hurt?

2011-12-29

Millions of people have undergone LASIK surgery throughout the world. As the most popular form of laser vision correction, it has been closely monitored by the FDA and several industry groups. In a recent analysis of over 60 studies worldwide, it was found that 95.4 percent of people who have received LASIK are very satisfied with their results. This same analysis found that LASIK was effective in providing vision of 20/20 or better in an overwhelming majority of instances. This is great news for people who long to live a life free of glasses, but it fails to address one ...

How obesity alters the brain area involved in body weight control

2011-12-29

The number of people who suffer from one or more of the adverse complications of obesity, including type 2 diabetes and heart disease is rapidly increasing. Thus far, drugs designed to treat obesity have shown limited efficacy and have been associated with serious side effects. This is largely because we have limited understanding of the effects of obesity on our natural mechanisms of body weight control. For example, while great strides have been made in our understanding of how the brain controls our desire to feed, as well as the processes underlying the balancing of ...

Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis

2011-12-29

Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis (i.e., heart attack and stroke). However, a team of researchers led by Gary Owens, at the University of Virginia, Charlottesville, has now generated data in mice that raise potential concerns about this clinical ...

JCI online early table of contents: Dec. 27, 2011

2011-12-29

EDITOR'S PICK Another potential obstacle to developing an HIV vaccine A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]). A team of researchers led by Juliana McElrath, at the Fred Hutchinson Cancer Research ...

Tests for biomarker may help determine diagnosis of heart attack within hours

2011-12-29

CHICAGO – For patients admitted to an emergency department with chest pain, use of a contemporary or highly sensitive test for levels of troponin I (a protein in muscle tissue) may help rule-out a diagnosis of heart attack, while changes in the measured levels of this biomarker at 3 hours after admission may be useful to confirm a diagnosis of heart attack, according to a study in the December 28 issue of JAMA. One of the most common reasons patients seek care in an emergency department is for acute chest pain. "Early identification of individuals at high and intermediate ...

Perception of inappropriate care frequent among ICU workers

2011-12-29

CHICAGO – A survey of nurses and physicians in intensive care units (ICUs) in Europe and Israel indicated that the perception of inappropriate care, such as excess intensity of care for a patient, was common, and that these perceptions were associated with inadequate decision sharing, communication and job autonomy, according to a study in the December 28 issue of JAMA. "Clinicians perceive the care they provide as inappropriate when they feel that it clashes with their personal beliefs and/or professional knowledge. Intensive care unit workers who provide care perceived ...

Analysis does not support genetic test before use of anti-clotting drug

2011-12-29

CHICAGO – Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA. Clopidogrel is an antiplatelet drug used by approximately 40 million patients worldwide to treat or prevent ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury